- UID
- 72869
- 在线时间
- 小时
- 注册时间
- 2005-1-28
- 最后登录
- 1970-1-1
- 主题
- 帖子
- 性别
- 保密
|
chunnuanhua 发表于 2013-6-5 15:41 ![]()
http://baike.baidu.com/view/3959149.htm
孔英,著名管理经济学家,加拿大卡尔顿大学经济系经济学博士, ...
York 比光华要差多了,孔英在光华连助理教授的位置都找不到。孟娟娟比孔英强多了。
Pseudo-generic products and barriers to entry in pharmaceutical marketsY Kong, JR Seldon - Review of Industrial Organization, 2004 - Springer
... wAuthor for Correspondence: Department of Economics, The University College of Cariboo,
Kamloops, BC, Canada V2C SN3. Tel.: +1-250-828-5000; E-mail: ykong@cariboo.bc.ca Review
of Industrial Organization 25: 71–86, 2004. ... YING KONG AND JAMES R. SELDON 72 ...
Cited by 30 Related articles All 5 versions Citesimidchiev.net [PDF]
The price premium of generic to brand-names and pharmaceutical price indexY Kong - Applied Economics, 2004 - Taylor & Francis
The price premium of generic pharmaceuticals to brand-names is examined under different
competitive market situations. The result of this study shows that the number, market share,
and the age of both brand-name and generic products have the most explanatory power ...
Cited by 15 Related articles All 10 versions Cite
Can health insurance coverage explain the generic competition paradox?I Ferrara, Y Kong - Economics Letters, 2008 - Elsevier
In the context of a three-stage model with consumers differing in their health insurance
coverage, the paper shows that there exist conditions under which the price of brand-name
drugs increases following the entry of generic drugs.
Cited by 10 Related articles All 4 versions Cite
|
|